References
Overlack, A. (1996). ACE inhibitor-induced cough and bronchospasm. Incidence, mechanisms and management. Drug Safety, 15, 72–78.
Hedner, T., Samuelsson, O., Lunde, H., Lindholm, L., Andren, L., & Wiholm, B. E. (1992). Angio-oedema in relation to treatment with angiotensin converting enzyme inhibitors. British Medical Journal, 304(6832), 941–946.
Agostoni, A., Aygoren-Pursun, E., Binkley, K. E., Blanch, A., Bork, K., Bouillet, L., et al. (2004). Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. The Journal of Allergy and Clinical Immunology, 114(3 Suppl), S51–S131.
Jackson, E. K. (2006). Renin and angiotensin. In: Goodman & Gilman’s the pharmacological basis of therapeutics (11th ed., pp. 789–821). New York: McGraw-Hill.
Agostoni, A., Cicardi, M., Cugno, M., Zingale, L. C., Gioffre, D., & Nussberger, J. (1999). Angioedema due to angiotensin-converting enzyme inhibitors. Immunopharmacology, 44(1–2), 21–25.
Molinaro, G., Cugno, M., Perez, M., Lepage, Y., Gervais, N., Agostini, A., et al. (2002). Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine9-bradykinin. Journal of Pharmacology and Experimental Therapeutics, 303(1), 232–237.
Sondhi, D., Lippmann, M., & Murali, G. (2004). Airway compromise due to angiotensin-converting enzyme inhibitor-induced angioedema: Clinical experience at a large community teaching hospital. Chest, 126(2), 400–404.
Quincke, H. (1882). Über akutes umschriebenes Hautödem. Monatsschr Prakt Dermat, 1, 129–131.
Morimoto, T., Gandhi, T. K., Fiskio, J. M., Seger, A. C., So, J. W., Cook, E. F., et al. (2004). An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors. Journal of Evaluation in Clinical Practice, 10(4), 499–509.
Nussberger, J., Cugno, M., Amstutz, C., Cicardi, M., Pellacani, A., & Agostoni, A. (1998). Plasma bradykinin in angio-oedema. The Lancet, 351(9117), 1693–1697.
Sánchez-Borges, M., & González-Aveledo, L. A. (2010). Angiotensin-converting enzyme inhibitors and angioedema. Allergy, Asthma and Immunology Research, 2(3), 195–198.
Burkhart, G. A., Brown, N. J., & Griffin, M. R. (1996). Angiotensin converting enzyme inhibitor associated angioedema: higher risk in blacks than in whites. Pharmacoepidemiology and Drug Safety, 5(3), 149–154.
Peltekis, G., Palaskas, D., Samanidou, M., Fragakis, A., Alexopoulos, K., Kotsani, A., et al. (2009). Severe migratory angioedema due to ACE inhibitors use. Hippokratia, 13(2), 122–124.
Talavera, A., Larraona, J. L., Ramos, J. L., Lopez, T., Maraver, A., Arias, J., et al. (1995). Hereditary angioedema: An infrequent cause of abdominal pain with ascites. American Journal of Gastroenterology, 90(3), 471–474.
Gelée, B., Michel, P., Haas, R., & Boishardy, F. (2008). Angiotensin-converting enzyme inhibitor-related angioedema: Emergency treatment with complement C1 inhibitor concentrate. Revue de Medecine Interne, 29(6), 516–519.
Decloedt, E., Freercks, R., & Maartens, G. (2009). Cerebral angioedema associated with enalapril. British Journal of Clinical Pharmacology, 68(2), 271–273.
Sarkar, P., Nicholson, G., & Hall, G. (2006). Brief review: Angiotensin converting enzyme inhibitors and angioedema: Anesthetic implications. Canadian Journal of Anaesthesia, 53(10), 994–1003.
Zingale, L. C., Beltrami, L., Zanichelli, A., Maggioni, L., Pappalardo, E., Cicardi, B., et al. (2006). Angioedema without urticaria: A large clinical survey. Canadian Medical Association Journal, 175(9), 1065–1070.
Vleeming, W., van Amsterdam, J. G., Stricker, B. H., & de Wildt, D. J. (1998). ACE inhibitor-induced angioedema: Incidence, prevention and management. Drug Safety, 18(3), 171–188.
Kostis, J. B., Kim, H. J., Rusnak, J., Casale, T., Kaplan, A., Corren, J., et al. (2005). Incidence and characteristics of angioedema associated with enalapril. Archives of Internal Medicine, 165(14), 1637–1642.
Adebayo, P. B., & Alebiosu, O. C. (2009). ACE-I induced angioedema: A case report and review of literature. Cases Journal, 2, 7181.
Nielsen, E. W., & Gramstad, S. (2006). Angioedema from angiotensin-converting enzyme (ACE) inhibitor treated with complement 1 (C1) inhibitor concentrate. Acta Anaesthesiologica Scandinavica, 50(1), 120–122.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
El Koraichi, A., Tadili, J., Benjelloun, M.Y. et al. Enapranil-Induced Angioedema in a 2-Year-Old Infant: Case Report. Cardiovasc Toxicol 11, 382–384 (2011). https://doi.org/10.1007/s12012-011-9130-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12012-011-9130-2